Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Biofrontera AG
DescriptionSerotonin (5-HT2B) receptor antagonist
Molecular Target Serotonin (5-HT2B) receptor
Mechanism of ActionSerotonin (5-HT2B) receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationMigraine
Indication DetailsPrevent migraine
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today